The T cell receptor (TCR)-cluster of differentiation 3 (CD3) signaling complex plays an important role in initiation of adaptive immune responses, but weak interactions have obstructed delineation of the individual TCR-CD3 subunit interactions during T cell signaling. Here, we demonstrate that unnatural amino acids (UAA) can be used to photo-cross-link subunits of TCR-CD3 on the cell surface. Incorporating UAA in mammalian cells is usually a low efficiency process. In addition, TCR-CD3 is composed of eight subunits and both TCR and CD3 chains are required for expression on the cell surface. Photo-cross-linking of UAAs for studying protein complexes such as TCR-CD3 is challenging due to the difficulty of transfecting and expressing multisubunit protein complexes in cells combined with the low efficiency of UAA incorporation. Here, we demonstrate that by systematic optimization, we can incorporate UAA in TCR-CD3 with high efficiency. Accordingly, the incorporated UAA can be used for site-specific photo-cross-linking experiments to pinpoint protein interaction sites, as well as to confirm interaction sites identified by X-ray crystallography. We systemically compared two different photo-cross-linkers--p-azido-phenylalanine (pAzpa) and H-p-Bz-Phe-OH (pBpa)--for their ability to map protein subunit interactions in the 2B4 TCR. pAzpa was found to have higher cross-linking efficiency, indicating that optimization of the selection of the most optimal cross-linker is important for correct identification of protein-protein interactions. This method is therefore suitable for studying interaction sites of large, dynamic heteromeric protein complexes associated with various cellular membrane systems.
The T cell receptor (TCR)-cluster of differentiation 3 (CD3) signaling complex plays an important role in initiation of adaptive immune responses, but weak interactions have obstructed delineation of the individual TCR-CD3 subunit interactions during T cell signaling. Here, we demonstrate that unnatural amino acids (UAA) can be used to photo-cross-link subunits of TCR-CD3 on the cell surface. Incorporating UAA in mammalian cells is usually a low efficiency process. In addition, TCR-CD3 is composed of eight subunits and both TCR and CD3 chains are required for expression on the cell surface. Photo-cross-linking of UAAs for studying protein complexes such as TCR-CD3 is challenging due to the difficulty of transfecting and expressing multisubunit protein complexes in cells combined with the low efficiency of UAA incorporation. Here, we demonstrate that by systematic optimization, we can incorporate UAA in TCR-CD3 with high efficiency. Accordingly, the incorporated UAA can be used for site-specific photo-cross-linking experiments to pinpoint protein interaction sites, as well as to confirm interaction sites identified by X-ray crystallography. We systemically compared two different photo-cross-linkers--p-azido-phenylalanine (pAzpa) and H-p-Bz-Phe-OH (pBpa)--for their ability to map protein subunit interactions in the 2B4TCR. pAzpa was found to have higher cross-linking efficiency, indicating that optimization of the selection of the most optimal cross-linker is important for correct identification of protein-protein interactions. This method is therefore suitable for studying interaction sites of large, dynamic heteromeric protein complexes associated with various cellular membrane systems.
T cells
play a central role
in adaptive immunity through regulation of responses by other immune
cells or directly attacking infected or cancerous cells. The T cell
receptor (TCR)-cluster of differentiation 3 (CD3) signaling complex
is responsible for mediating specific CD4+ and CD8+ T cell responses
to self- and foreign antigens.[1] TCR-CD3
is composed of disulfide-linked TCRαβ heterodimers and
noncovalently associated CD3εδ, CD3εγ heterodimers,
and CD3ζζ homodimers.[2] The
complementarity determining regions (CDRs) of the TCRαβ
variable regions are responsible for antigen–major histocompatibility
complex (MHC) recognition,[3] while the long
cytoplasmic tails of CD3 are vital in propagating the triggered TCR
signal and interacting with the intracellular signaling machinery.[4] Therefore, expression of both TCR and CD3 chains
is required on the cell surface to trigger T cell responses. In addition,
TCRαβ has to be assembled into a complex with the CD3εδ,
εγ, and ζζ dimers in order to reach the cell
surface.[5−8] Thus, TCR-CD3 represents a multichain membrane signaling protein
complex that is very challenging to study. Although biophysical and
biochemical studies using soluble, purified proteins have provided
a wealth of information on the structure and function of TCR-CD3,[3,9] problems arise due to the transient and/or low-affinity interactions
among the macromolecules, which are not maintained when the proteins
are removed from their cellular context.[5] Furthermore, because TCR-CD3 is membrane-associated, the membrane
environment regulates its structure, interactions, and function.[10] One strategy to circumvent these challenges
is to incorporate photoactivatable unnatural amino acid (UAA) cross-linkers
at specific sites in TCR-CD3 to covalently cross-link and capture
the interactions among the signaling complex subunits as they occur
in a native membrane environment. Here, we demonstrate the feasibility
of this approach by incorporating UAAs into the TCR and cross-linking
TCRα and β chains. This approach could be a powerful tool
for investigating TCR and CD3 interactions to reveal T cell signaling
mechanism in mammalian cells.Incorporation of UAAs is a powerful
method for studying protein–protein
interactions. Different UAAs bearing unique side chains, such as benzophenone,
aryl azide, and diazirine[11−15] can be genetically incorporated into proteins in live cells through
reprogramming the genetic code.[16] Briefly,
orthogonal tRNA-aminoacyl-tRNAsynthetases (tRNA-aaRS), which are engineered
to incorporate UAAs in response to unique codons, such as the amber
stop codon TAG, are introduced into live cells. As a result, when
UAAs are present in the tissue culture medium, the engineered tRNA-aaRS
allows incorporation of UAA into the nascent protein by the ribosome
at the TAG site. This approach provides a convenient way to site-specifically
modify proteins with UAAs bearing unique side chains. Previously,
UAAs have been genetically incorporated in Escherichia coli,[17] yeast,[18,19] and mammalian
cells[12,20−25] using tRNA-aaRS pairs. However, the incorporation efficiency is
generally low in mammalian cells.[23] Improving
UAA incorporation efficiency by optimizing orthogonal tRNA-aaRS expression[24−26] or improving tRNA-aaRS affinity[23] has
been pursued; however, the incorporation and application of UAAs in
multisubunit signaling protein complexes such as TCR-CD3 has not been
extensively examined.Here, we report the successful genetic
incorporation of the photoactivatable
amino acids p-azido-phenylalanine (pAzpa) and H-p-Bz-Phe-OH (pBpa)[25] into the TCRα chain of TCR-CD3 in its
native membrane environment in mammalian cells. We demonstrate that,
after systematic optimization, UAA cross-linkers can be incorporated
with high efficiency to probe specific interactions among a membrane
protein complex such as TCR-CD3. We used the mouse2B4TCR,[27] and by incorporating the photo-cross-linkers
into the TCRα chain, we were able to confirm specific interaction
sites that were previously defined by X-ray crystallography.[28] Our result supports the hypothesis that this
technique could potentially be widely used to probe interactions among
complexes formed by weak interactions. In addition, as UAAs can be
incorporated at specific protein sites, they can be used to pinpoint
interaction sites between proteins that are difficult to assess by
traditional methods of immunoprecipitation and cross-linking with
nonspecific chemicals.
Results and Discussion
Incorporation of Unnatural
Amino Acids into the 2B4 TCR
To test the feasibility of site-specific
photo-cross-linking of TCR
subunits, we used amber codon suppression to genetically incorporate
UAAs with photo-cross-linking abilities into the previously biochemically
and structurally well-characterized 2B4TCR.[28] We used the X-ray crystal structure of 2B4TCR (PDB: 3QJF)[28] (Figure 1a) to identify three amino
acids (Arg39, Gly40, and Ser41) from the α chain that are in
close contact with the β chain. The shortest distances calculated
between the chosen amino acids to nearest atoms on the β chain
were 2.62, 3.92, and 3.68 Å for Arg39, Gly40, and Ser41, respectively
(Supporting Information Table S1), and
are generally thought to be within the distance needed for cross-linking.[20] A TAG stop codon was incorporated into the recombinant
cDNA at the position encoding each amino acid. As a negative control
we selected an amino acid, Lys65, that is distant from the TCRβ
chain, such that cross-linking is not expected to occur. We compared
two UAA photo-cross-linkers–pAzpa and pBpa (Figure 1b)—which have different sizes, photoreactive
mechanisms, and cross-linking amino acid preferences.[29,30]
Figure 1
Structural
illustration of 2B4 TCR and UAAs. (a) Ribbon diagram
representation of the 2B4 TCR (PDB: 3QJF) with TCRα chain in cyan and TCRβ
chain in gray. Residues mutated for UAA incorporation are Ser41 (red),
Arg39 (orange), Gly40 (yellow), and Lys65 (pink). When calculating
distance of the selected residues using center of mass of amino acids
to main chain atoms of TCRβ chain, Ser41 shows the shortest
distance to its interaction site Pro107 (dark blue). When considering
UAA cross-linking preference, the closest pairs of residues are Ser41
(red) with Phe105 (light blue), Arg39 (orange) with S158 (purple),
and Gly40 (yellow) with Thr109 (purple). (b) Structures of the UAA
photo-cross-linkers pAzpa and pBpa.
Structural
illustration of 2B4TCR and UAAs. (a) Ribbon diagram
representation of the 2B4TCR (PDB: 3QJF) with TCRα chain in cyan and TCRβ
chain in gray. Residues mutated for UAA incorporation are Ser41 (red),
Arg39 (orange), Gly40 (yellow), and Lys65 (pink). When calculating
distance of the selected residues using center of mass of amino acids
to main chain atoms of TCRβ chain, Ser41 shows the shortest
distance to its interaction site Pro107 (dark blue). When considering
UAA cross-linking preference, the closest pairs of residues are Ser41
(red) with Phe105 (light blue), Arg39 (orange) with S158 (purple),
and Gly40 (yellow) with Thr109 (purple). (b) Structures of the UAA
photo-cross-linkers pAzpa and pBpa.The selected amino acids were predicted to cross-link with
varying
degrees of efficiency (Arg39, Gly40, Ser41) or not to cross-link (Lys65).
For those predicted to cross-link, we also calculated which TCRβ
atoms fall into a 9–10 Å radius, indicating potential
cross-linking partners (Supporting Information
Table S2). Based on these measurements, all three selected
residues have numerous potential cross-linking partners within an
appropriate distance.
To optimize the incorporation of UAA into the 2B4TCR, we analyzed
the efficiency of different orthogonal amber suppressor tRNA-aminoacyl-tRNAsynthetase
(tRNA-aaRS) constructs, including PSWAN-pAzpa,[25] EAziRS,[23] PU6-pAzpa, and PU6-EAziRS
for pAzpa incorporation; and PSWAN-pBpa,[25] EBzoRS,[23] PU6-pBpa, and PU6-EBzoRS for
pBpa incorporation. The construction of PSWAN-pAzpa/pBpa (PSWAN plasmids),
PU6-pAzpa/pBpa/EAziRS/EBzoRS (PU6 plasmids), and EAziRS/EBzoRS is
illustrated in Figure 2a. The construction
of PSWAN-pAzpa/pBpa has previously been described.[25] Briefly, the PSWAN plasmid has three copies of B. stearothermophilus tRNAs(BstRNA) and a mutant E. coli tyrosyl-tRNA synthetase (EcTyrRS). The BstRNA has
naturally occurring internal A and B boxes recognized by RNA polymerase
III in eukaryotes. The PU6 plasmid was modified from the PSWAN backbone
with one copy of BstRNA and a human U6 small nuclear promoter (U6)
added to improve the efficiency of expression of tRNAs. The EBzoRS
and EAziRS plasmids include a pol III promoter H1,[23,31] EctRNA, and EcTyrRS.[20] The orthogonal
tRNA-aaRS plasmids were cotransfected with the PSWAN-GFP37TAG[25] plasmid, which has an amber stop mutation at
position Tyr37 of GFP, into HumanEmbryonic Kidney (HEK) 293 T cells
followed by addition of the UAAspAza and pBpa to the tissue culture
medium. GFP expression was quantified 48 h after transfection using
flow cytometry to directly compare the efficiency of UAA incorporation.
We observed that PU6-pAzpa and PU6-EAziRS had significantly higher
expression of GFP than PSWAN-pAzpa and EAziRS with pAzpa incorporation
(Figure 2b), which suggested that the U6 promoter
in the PU6-pAzpa or PU6-EAziRS constructs may play an important role
in promoting tRNA expression, subsequently enhancing the UAA incorporation
efficiency. Similarly, we observed that PU6-pBpa and PU6-EBzoRS had
higher expression of GFP than PSWAN-pBpa and EBzoRS with pBpa incorporation.
Importantly, PSWAN-GFP37TAG contains not only the GFP reporter but
also three copies of a cassette expressing BstRNA and therefore contributes
to a background of tRNA cassette in our experiments. Therefore, the
quantification of the precise fold increase that is contributed by
the promoter cannot be calculated due to this general background.
However, our data shows that PU6 plasmids are the most efficient.
Figure 2
U6 promoter
increases UAA incorporation efficiency. (a) Schematic
illustration of different tRNA-aaRS expression plasmids. The PSWAN
plasmid (PSWAN_pAzpa/pBpa) has three copies of B. stearothermophilus tRNAs(BstRNA) and a mutant E. coli tyrosyl-tRNA
synthetase (EcTyrRS). The BstRNA has naturally occurring internal
A and B boxes recognized by the RNA polymerase III in eukaryotes.
The PU6 (PU6_pAzpa/pBpa/EBzoRS/EAziRS) plasmid has one copy of BstRNA
and a human U6 small nuclear promoter (U6) added to improve the efficiency
of expression of tRNAs. The EBzoRS and EAziRS plasmids include a pol
III promoter H1,[23,31] EctRNA, and EcTyrRS.[20] (b) Total GFP intensity with pAzpa (left) and
pBpa (right) incorporation after transfection of tRNA-aaRS and PSWAN-GFP37TAG
plasmids to HEK293 T cells. GFP fluoresecence intensity was quantified
by flow cytometry. Error bars represents Standard Error of the Mean
(SEM); n = 3 a.u. represents arbitrary unit.
U6 promoter
increases UAA incorporation efficiency. (a) Schematic
illustration of different tRNA-aaRS expression plasmids. The PSWAN
plasmid (PSWAN_pAzpa/pBpa) has three copies of B. stearothermophilus tRNAs(BstRNA) and a mutant E. coli tyrosyl-tRNA
synthetase (EcTyrRS). The BstRNA has naturally occurring internal
A and B boxes recognized by the RNA polymerase III in eukaryotes.
The PU6 (PU6_pAzpa/pBpa/EBzoRS/EAziRS) plasmid has one copy of BstRNA
and a human U6 small nuclear promoter (U6) added to improve the efficiency
of expression of tRNAs. The EBzoRS and EAziRS plasmids include a pol
III promoter H1,[23,31] EctRNA, and EcTyrRS.[20] (b) Total GFP intensity with pAzpa (left) and
pBpa (right) incorporation after transfection of tRNA-aaRS and PSWAN-GFP37TAG
plasmids to HEK293 T cells. GFP fluoresecence intensity was quantified
by flow cytometry. Error bars represents Standard Error of the Mean
(SEM); n = 3 a.u. represents arbitrary unit.
Efficient Incorporation
of UAA in the 2B4 TCR/CD3 Signaling
Complex
The TCR-CD3 signaling complex is composed of the
disulfide-linked TCRαβ heterodimer and the noncovalently
associated CD3εδ, εγ, and ζξ chains,
all of which are required for efficient expression at the cell surface.[32,33] The difficulty of transfecting and expressing multiple subunits
of TCR-CD3, combined with generally low UAA incorporation efficiency
in mammalian cells is a major technical barrier to the use of UAA
incorporation in studying the TCR-CD3 complex. To facilitate stoichiometric
expression of different subunits, self-cleavable 2A peptide linkers
were used to connect TCRα and β chains or CD3δ,
ε, γ, and ξ chains.[34] Subsequently, constructs containing TCR and CD3 were cotransfected
with tRNA-aaRS constructs into HEK293 T cells. We investigated how
the ratio and total amount of TCR/CD3 DNA influences the surface expression
of TCR after UAA incorporation. We cotransfected 2.5 μg of tRNA-aaRS
plasmid DNA with 2.5 μg, 5 μg or 7.5 μg of TCR and
CD3 plasmid DNA into HEK293 T cells. We also varied the ratio of TCR:CD3
from 8:1, 4:1, 2:1, and 1:1 (Figure 3). TCR
expression was quantified by flow cytometry. We found that 7.5 μg
of TCR and CD3 total plasmid DNA is optimal for transfection and that
8:1 weight ratio of TCR/CD3 has the highest TCR expression (around
100-fold increase compared to the lowest TCR expression) (Figure 3).
Figure 3
Efficient incorporation of UAA into the 2B4 TCR/CD3 signaling
complex.
Influence of TCR/CD3 ratio and transfection amount for TCR surface
expression when using pAzpa (a) versus pBpa (b) for incorporation.
We transfected 2.5 μg, 5 μg or 7.5 μg of TCR and
CD3 plasmid DNA into HEK293 T cells. We also varied the ratio of TCR/CD3
plasmid DNA from 8:1, 4:1, 2:1, and 1:1. TCR expression was quantified
by PE-conjugated anti-TCR Vβ3 staining followed by flow cytometry
analysis.
Efficient incorporation of UAA into the 2B4TCR/CD3 signaling
complex.
Influence of TCR/CD3 ratio and transfection amount for TCR surface
expression when using pAzpa (a) versus pBpa (b) for incorporation.
We transfected 2.5 μg, 5 μg or 7.5 μg of TCR and
CD3 plasmid DNA into HEK293 T cells. We also varied the ratio of TCR/CD3
plasmid DNA from 8:1, 4:1, 2:1, and 1:1. TCR expression was quantified
by PE-conjugated anti-TCR Vβ3 staining followed by flow cytometry
analysis.
Optimization of Photo-Cross-Linking
Time Is Important for Efficient
UAA Incorporation
After incorporation of pAzpa or pBpa into
the TCR, photo-cross-linking was performed for varied lengths of time
(0, 15, 30, 45, 60, 90 min) to identify the UV-exposure time to obtain
maximum photo-cross-linking efficiency of TCRα and β chains.
After in-cell photo-cross-linking using UV at 365 nm, TCR-CD3 complex
was precipitated using biotin-labeled anti-CD3ε[35] antibody, followed by purification with streptavidin beads.
After purification, the subunits were separated in the presence of
a reducing agent by SDS-PAGE, followed by Western blot analysis to
detect individual TCR subunits and cross-linked complexes. To facilitate
Western blot detection of TCRβ chain, a V5 epitope tag was introduced
after the TCRβ chain so that the presence of TCRβ in the
cross-linked complex could be directly detected using an anti-V5 antibody.
The expression of the wild type 2B4TCR, 2B4TCR with the Ser41 mutation,
and negative control 2B4TCR with the Lys65 mutation on the α
chain is shown in Figure 4a. The expression
levels of the Ser41 and Lys65 mutants were similar and were both lower
than wild-type 2B4TCR. To determine cross-linking efficiency, the
blots were probed with anti-TCRα Va11.1 antibody and anti-V5
antibodies. Cross-linking efficiency was quantified using the ratio
of cross-linked compound intensity to non-cross-linked TCR intensity
(Figure 4b). Non-cross-linked TCRα and
β chains migrate at apparent molecular masses between 37 and
50 kDa, and cross-linked TCRα and β chains migrate at
apparent molecular masses between 75 and 100 kDa (Figure 4b and Supporting Information
Figure 1). pAzpa efficiently cross-linked TCRα and β
chains in 15 min, and its efficiency increased when cross-linking
time was increased up to 45 min (Figure 4c).
Longer cross-linking times, however, did not increase photo-cross-linking
efficiency (Figure 4c). Cross-linking with
pBpa produced similar results. Overall, cross-linking times between
15 and 45 min are favorable for both cross-linkers.
Figure 4
In-cell surface protein
photo-cross-linking. (a) TCRs were expressed
on the cell surface at lower levels than WT after pAzpa incorporation.
Two amino acids Ser41 and Lys65 (non-cross-linking control) on TCRα
were mutated to incorporate UAA. TCR expression was quantified by
PE-conjugated anti-TCR Vβ3 staining followed by flow cytometry
analysis. (b) Cells expressing TCRs with pAzpa incorporated were cross-linked
under 365 nm UV light for 0 min, 15 min, 30 min, 45 min, 60 min, or
90 min. Then, cells were lysed, and TCR-CD3 complexes were immunoprecipitated
with biotin anti-CD3ε and probed with anti-TCRα antibody
using Western blot. Lower bands between 37 and 50 KD represent non-cross-linked
TCRα chain and upper bands between 75 and 100 KD represent cross-linked
TCRα and β chains. (c) Quantification of cross-linking
efficiency at different cross-linking incubation times. We quantify
the cross-linked complex band and non-cross-linked bands from Western
blot image. Cross-linking efficiency was calculated using the ratio
of cross-linked compound intensity to non-cross-linked TCR intensity
from Western blot image.
In-cell surface protein
photo-cross-linking. (a) TCRs were expressed
on the cell surface at lower levels than WT after pAzpa incorporation.
Two amino acids Ser41 and Lys65 (non-cross-linking control) on TCRα
were mutated to incorporate UAA. TCR expression was quantified by
PE-conjugated anti-TCR Vβ3 staining followed by flow cytometry
analysis. (b) Cells expressing TCRs with pAzpa incorporated were cross-linked
under 365 nm UV light for 0 min, 15 min, 30 min, 45 min, 60 min, or
90 min. Then, cells were lysed, and TCR-CD3 complexes were immunoprecipitated
with biotin anti-CD3ε and probed with anti-TCRα antibody
using Western blot. Lower bands between 37 and 50 KD represent non-cross-linked
TCRα chain and upper bands between 75 and 100 KD represent cross-linked
TCRα and β chains. (c) Quantification of cross-linking
efficiency at different cross-linking incubation times. We quantify
the cross-linked complex band and non-cross-linked bands from Western
blot image. Cross-linking efficiency was calculated using the ratio
of cross-linked compound intensity to non-cross-linked TCR intensity
from Western blot image.
pAzpa is More Efficient at Photo-Cross-Linking TCRα and
β Chains Compared with pBpa
To further investigate
the specificity of the in-cell photo-cross-linking approach and to
compare pAzpa and pBpa photo-cross-linking efficiency, we performed
cross-linking experiments for TCRα and β chains using
pAzpa and pBpa. We quantified TCR and CD3 expression by flow cytometry
using anti-TCRβ and anti-CD3ε antibodies 48h post-transfection
of HEK293 T cells. TCR with pAzpa (Figure 5a) or pBpa (Figure 5b) incorporated at Arg39,
Gly40, Ser41, and Lys65 were expressed on the cell surface at comparable
levels. Expression of TCR with incorporation of pAzpa was lower than
wild type 2B4TCR (Figure 5a), while expression
of TCR with incorporation of pBpa was comparable to wild type levels
(Figure 5b). However, in both cases CD3 was
well expressed on the cell surface, which suggests that the incorporation
of UAA in the 2B4TCR has limited influence on CD3 expression and
does not interfere with TCR interactions with CD3. After photo-cross-linking
for 30 min, TCR cross-linking efficiency was evaluated by immunoprecipitation
and Western blot analysis (Figure 5c and d).
Cross-linked TCRα and β chains were visualized by colocalization
of anti-TCRα and anti-V5 antibodies (Figure 5c and d). Consistent with the X-ray crystallography data,
the pAzpa and pBpa showed functional cross-linking when incorporated
at positions Arg39, Gly40, and Ser41, but not at the control Lys65
position (Figure 5c and d), demonstrating the
specificity of cross-linking. In all, when comparing the cross-linking
efficiency of pAzpa and pBpa through the relative intensities of the
bands corresponding to the cross-linked product (Figure 5e), pAzpa exhibited higher cross-linking efficiency than pBpa
at the specific cross-linking sites chosen in our study.
Figure 5
pAzpa is more
efficient in cross-linking TCR subunits than pBpa.
TCR and CD3 expression with (a) pAzpa and (b) pBpa incorporated on
different sites of the TCRα chain. TCR and CD3 expression was
quantified by PE-conjugated anti-TCR Vβ3 and APC-conjugated
anti-CD3ε (145-2C11) staining followed by flow cytometry analysis.
Photo-cross-linking of TCRα and β chains with (c) pAzpa
and (d) pBpa as photo-cross-linkers. Cells expressing TCRs with pAzpa
or pBpa incorporated were cross-linked by UV light (365 nm) for 30
min. Immunoprecipitation with biotin anti-CD3ε followed by Western
blotting using anti-TCRα and anti-V5 antibodies were performed
after UV-cross-linking. Lower bands between 37 and 50 KD represent
non-cross-linked TCRα or β chain and upper bands between
75 and 100 KD represent cross-linked TCRα and β chains.
Wild type 2B4 TCR and Lys65 are used as non-cross-linking control.
(e) Quantification of cross-linking efficiency calculated from cross-linked
and non-cross-linked band from Western blot image. Error bars represents
SEM, n = 2. (c) Quantification of cross-linking efficiency
at different cross-linking incubation times. We quantify the cross-linked
complex band and non-cross-linked bands from Western blot image. Cross-linking
efficiency was calculated using the ratio of cross-linked compound
intensity to non-cross-linked TCR intensity from Western blot image.
pAzpa is more
efficient in cross-linking TCR subunits than pBpa.
TCR and CD3 expression with (a) pAzpa and (b) pBpa incorporated on
different sites of the TCRα chain. TCR and CD3 expression was
quantified by PE-conjugated anti-TCR Vβ3 and APC-conjugated
anti-CD3ε (145-2C11) staining followed by flow cytometry analysis.
Photo-cross-linking of TCRα and β chains with (c) pAzpa
and (d) pBpa as photo-cross-linkers. Cells expressing TCRs with pAzpa
or pBpa incorporated were cross-linked by UV light (365 nm) for 30
min. Immunoprecipitation with biotin anti-CD3ε followed by Western
blotting using anti-TCRα and anti-V5 antibodies were performed
after UV-cross-linking. Lower bands between 37 and 50 KD represent
non-cross-linked TCRα or β chain and upper bands between
75 and 100 KD represent cross-linked TCRα and β chains.
Wild type 2B4TCR and Lys65 are used as non-cross-linking control.
(e) Quantification of cross-linking efficiency calculated from cross-linked
and non-cross-linked band from Western blot image. Error bars represents
SEM, n = 2. (c) Quantification of cross-linking efficiency
at different cross-linking incubation times. We quantify the cross-linked
complex band and non-cross-linked bands from Western blot image. Cross-linking
efficiency was calculated using the ratio of cross-linked compound
intensity to non-cross-linked TCR intensity from Western blot image.The use of UAAs to study the interactions
of membrane protein complexes
such as the TCR signaling complex is challenging due to inefficient
UAA incorporation and low protein yields. In our study, we found that
driving tRNA expression by a human U6 small nuclear promoter (U6)
can significantly increase UAA incorporation efficiency. This result
is supported by previous studies that showed that the U6 promoter,
which successfully expresses short interfering RNAs in mammalian cells,
can greatly promote the expression of orthogonal E. coli tRNA in mammalian cells and is more efficient than the human H1
promoter (H1).[24,36] In addition, the U6 promoter
has previously been used to increase tRNA expression for the successful
application of UAAs in studying G protein-coupled receptors and their
binding path.[37] Our system for incorporating
UAAs in TCR-CD3 complexes includes three plasmids encoding tRNA-aaRS,
TCR, and CD3. We increased the amount of plasmid DNA to improve transfection
efficiency, and we optimized the TCR/CD3 plasmid DNA ratio to ensure
optimal expression of both TCR and CD3. Together, these approaches
resulted in high UAA incorporation efficiency in TCR-CD3.pBpa[12,25] is generally used in photo-cross-linking,
with few examples using pAzpa.[38] Benzophenones
(pBpa) are activated by relatively long wavelength light (350–365
nm)[29] compared to aryl azides (pAzpa) (<330
nm).[39] Therefore, pBpa would be expected
to minimize the incidence of nonspecific cross-linking and nucleic
acid damage. However, we found that pAzpa can be efficiently photoactivated
at the longer wavelength of 365 nm when incorporated into proteins,
and we obtained higher cross-linking efficiency with pAzpa than pBpa.
The reasons for this might be the following: first, benzophenone is
more selective, exhibiting a strong preference to react with methionine;[29] the cross-linking efficiency might be influenced
by this preference. Second, benzophenone is bigger than aryl azides,
making it more susceptible to geometric constraints when reacting
with other residues. Thus, the smaller size of aryl azides may be
advantageous in protein interactions that are more sensitive to perturbations.
Generally, we obtained more efficient cross-linking when using pAzpa.
However, as the previous literature has shown that different results
with pAzpa and pBpa can be obtained when incorporated at different
positions and under different experimental conditions,[38] comparing the two cross-linkers for each individual
protein under specific experimental conditions might be optimal.In all, we have successfully incorporated UAAs into a TCR-CD3 membrane
protein complex, and our results demonstrate the feasibility of this
method in studying TCR subunit interactions by photo-cross-linking.
This technique can be useful in studying complex protein interactions,
since theoretically, the UAA photo-cross-linker can be site-specifically
incorporated at any site of a protein. In our study, we utilized this
technique to identify the interaction sites between two protein subunits,
which verify the interaction sites identified by crystallography.
In addition, the results can be taken as evidence that the structure
resolved in the crystal corresponds at least partly to the “real”
structure in its native environment, although a more extensive cross-linking
study would be needed to confirm this. In addition, this technique
can be used to capture protein interactions at various stages in the
signal transduction process, since the photo-cross-linker can be excited
at relevant time-scales.
Methods
Plasmid Construction
The PSWAN-pAzpa, PSWAN-pBpa,[25] and PU6-pBpa
plasmids were generous gifts from
Dr. Peter G. Schultz at the Scripps Research Institute. The EBzoRS
and EAziRS plasmids[23] were generous gifts
from Dr. Lei Wang at the Salk Institute for Biological Studies. We
replaced cDNA encoding the tRNA synthetase for recognition of pBpa
in PU6-pBpa plasmid with tRNA synthetase in PSWAN-pAzpa,[25] EAziRS, and EBzoRS[23] to create PU6-pAzpa, PU6-EaziRS, and PU6-EBzoRS. cDNA encoding 2B4TCRα and β chains[14,15,40] was subcloned into the pcDNA3.1/Zeo (+) vector (Life Technologies)
using NotI and XhoI restriction enzymes. Similarly, cDNAs encoding
mouseCD3δ, CD3ε, and CD3γ chains were subcloned
into the pcDNA3.1/Zeo (+) vector using NotI and EcoRI restriction enzymes. Self-cleavable 2A peptides were introduced
for optimal TCR and CD3 expression, as previously described.[34] A V5 epitope tag was added to the C-terminus
of TCRβ for the detection of TCRβ in Western blot analysis.
Site-specific amber stop codons (TAG), used to facilitate nonspecific
amino acid incorporation, were introduced into 2B4TCR sequence using
the QuikChange Site-Directed Mutagenesis Kit (Stratagene).
Expression
of 2B4 TCR with UAA Mutants in Mammalian Cells
HEK293 T cells
were transfected with three plasmids expressing
tRNA-aaRS, 2B4TCR, and CD3εδ, εγ, ζζ
using the Xfect Transfection Reagent (Clontech). The day before transfection,
0.5 million cells were plated in a well of a 6-well cell culture plate
to obtain approximately 60% confluence at the time of transfection.
For transfection, Xfect polymer was mixed with plasmids and added
to the cell culture medium. After a 4 h incubation at 37 °C in
5% CO2, the transfection reagent mixture was replaced with
DMEM medium containing 1 mM of either 4-azido-l-phenylalanine
(pAzpa) (Chem-Impex International) or H-p-Bz-Phe-OH (pBpa) (Bachem).
Cells were used for photo-cross-linking experiments 48 h post-transfection
to allow expression of TCR and CD3 molecules on the cell surface.
Flow Cytometry Analysis
Cells were collected 48 h post-transfection
and stained with PE-conjugated anti-TCR Vβ3 (BD Pharmingen)
and APC-conjugated anti-CD3ε (145-2C11) (BD Pharmingen) in FACS
Buffer (PBS, 2% (v/v) FBS, 0.1% (w/v) sodium azide) for 30 min. Subsequently,
the samples were run on BD LSRII and data was analyzed by Flowjo 7.6
(TreeStar) for expression of TCR and CD3 proteins.
Photo-Cross-Linking,
Surface Immunoprecipitation and Western
Blots
To photo-cross-link TCRα and β chains,
cells were first transfected with the appropriate plasmid mixtures,
then collected and plated in 6-well tissue culture plates (BD Biosciences)
and finally photo-cross-linked by exposing the cells to 365 nm UV-light
using a UVP CL-1000 ultraviolet cross-linker instrument for different
times as outlined in individual experiments. After photo-cross-linking,
cells were treated with 25 μg/mL CD16/CD32 (BD Pharmingen) for
30 min, followed by treatment with 25 μg/mL H57 (BD Pharmingen)
for 30 min. Next, 25 μg/mL biotinylated mouse anti-CD3ε
(145-2C11) (eBioscience) was added for 30 min. Cells were washed between
each treatment after photo-cross-linking with ice-cold HBSS (Hank’s
balanced salt solution) /2% (v/v) FBS/0.05% (m/v) sodium azide. Afterward,
cells were lysed in TBS (Tris-buffered saline) (pH 8.0) /1% (v/v)
IGEPAL-CA630 (Sigma) containing 1X Complete protease inhibitors (Roche)
for 30 min. The TCR/CD3 complex was purified by adding Dynabeads M-280
Streptavidin (Life Technologies) to the lysis supernatant. The beads
were boiled in PBS, 0.1% (m/v) SDS with SDS-PAGE reducing buffer with
β-mercaptoethanol (Boston BioProducts). TCR-CD3 complexes were
resolved by SDS-PAGE gel and transferred to nitrocellulose membrane
(Life Technologies). In subsequent Western blot analysis, membranes
were first probed with an anti-TCR Va11.1 antibody (BD Biosciences)
and a rabbit anti-V5 antibody (Genscript), followed by corresponding
secondary antibodies—IRDye 680LT-conjugated donkey anti-mouse
IgG (H + L) or IRDye 800CW-conjugated donkey anti-goat IgG (H + L)
(LI-COR Biosciences). Images were collected using Odyssey machine
(LI-COR Biosciences) and analyzed using ImageJ or Image Studio Lite
(LI-COR Biosciences). To quantify cross-linking efficiency based on
Western blot, Image Studio Lite (LI-COR Biosciences) was used to quantify
the intensity of the cross-linked protein bands and non-cross-linked
protein bands. Subsequently, the ratio of cross-linked to non-cross-linked
bands was calculated to obtain the cross-linking efficiency.
Authors: N P Gritsan; A D Gudmundsdóttir; D Tigelaar; Z Zhu; W L Karney; C M Hadad; M S Platz Journal: J Am Chem Soc Date: 2001-03-07 Impact factor: 15.419
Authors: Wenyuan Wang; Jeffrey K Takimoto; Gordon V Louie; Thomas J Baiga; Joseph P Noel; Kuo-Fen Lee; Paul A Slesinger; Lei Wang Journal: Nat Neurosci Date: 2007-07-01 Impact factor: 24.884
Authors: Cassandra Koole; Christopher A Reynolds; Juan C Mobarec; Caroline Hick; Patrick M Sexton; Thomas P Sakmar Journal: J Biol Chem Date: 2017-03-10 Impact factor: 5.157
Authors: Alexander R Nödling; Luke A Spear; Thomas L Williams; Louis Y P Luk; Yu-Hsuan Tsai Journal: Essays Biochem Date: 2019-07-03 Impact factor: 8.000